1. Home
  2. FEAM vs IMUX Comparison

FEAM vs IMUX Comparison

Compare FEAM & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 5E Advanced Materials Inc.

FEAM

5E Advanced Materials Inc.

N/A

Current Price

$3.49

Market Cap

89.1M

Sector

Industrials

ML Signal

N/A

Logo Immunic Inc.

IMUX

Immunic Inc.

N/A

Current Price

$0.58

Market Cap

85.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FEAM
IMUX
Founded
2016
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.1M
85.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FEAM
IMUX
Price
$3.49
$0.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$8.13
$6.00
AVG Volume (30 Days)
79.2K
1.3M
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$500.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.82
$0.56
52 Week High
$24.84
$1.39

Technical Indicators

Market Signals
Indicator
FEAM
IMUX
Relative Strength Index (RSI) 37.40 32.49
Support Level $3.68 $0.58
Resistance Level $4.21 $0.70
Average True Range (ATR) 0.27 0.04
MACD -0.01 -0.01
Stochastic Oscillator 12.80 3.24

Price Performance

Historical Comparison
FEAM
IMUX

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: